Conference Posters Research Articles

How to develop and present a conference poster.

Conference posters can be used by nurses to disseminate the findings of studies, audits or service improvement projects. Despite the lack of robust evidence on what an optimal poster should include, the literature contains several sources of useful information on the topic. A conference poster requires thorough and systematic preparation; authors will need to determine what message they want to convey, what the aim of their poster is, and how they will ensure precision, clarity, brevity and visual appeal. This article provides a step-by-step guide to assist nurses in developing optimal poster content and design, and in delivering effective poster presentations. REFLECTIVE ACTIVITY: 'How to' articles can help to update your practice and ensure it remains evidence based. Apply this article to your practice. Reflect on and write a short account of.

Evidence for prereg posters as a platform for preregistration

Prereg posters are conference posters that present planned scientific projects. We provide preliminary evidence for their value in receiving constructive feedback, promoting open science and supporting early-career researchers.

Role of infection in wound healing

Chronic wounds, particularly infected wounds are clinically very important due to their significant impact on health budgets as well as patients` health worldwide. Patients with diabetes mellitus, vascular diseases especially peripheral vascular disease and pressure ulcers are major categories of patients presenting with chronic wounds. It is known that there are multiple factors determining chronic wound prognosis. The presence of multiple types of pathogenic bacteria, with specific virulence and adherent (biofilm) properties, contribute a significant role to the development of chronic wounds. This review article is based on the research project entitled” An investigation of the impact of bacterial diversity, pathogenic determinants and biofilms on chronic wounds”. The research findings have been published in form of research papers as well as conference posters. The aim of this article is to highlight various important aspects of bacterial impact on wound healing.
 Bangladesh Journal of Medical Science Vol.19(4) 2020 p.598-602

Text Recycling in STEM Research: An Exploratory Investigation of Expert and Novice Beliefs and Attitudes

When writing journal articles, science, technology, engineering and mathematics (STEM) researchers produce a number of other genres such as grant proposals and conference posters, and their new articles routinely build directly on their own prior work. As a result, STEM authors often reuse material from their completed documents in producing new documents. While this practice, known as text recycling (or self-plagiarism), is a debated issue in publishing and research ethics, little is known about researchers’ beliefs about what constitutes appropriate practice. This article presents results of from an exploratory, survey-based study on beliefs and attitudes toward text recycling among STEM “experts” (faculty researchers) and “novices” (graduate students and post docs). While expert and novice researchers are fairly consistent in distinguishing between text recycling and plagiarism, there is considerable disagreement about appropriate text recycling practice.

Using AphasiaBank for Discourse Assessment.

AphasiaBank is a shared, multimedia database for the study of communication in aphasia. This article describes a variety of discourse measurement tools and teaching resources available at the AphasiaBank website. The discourse measurement tools include main concept analysis, core lexicon checklists, correct information unit computation techniques, and other automated analyses using the CLAN program. These tools can be used to measure a variety of aspects of language production for assessment as well as treatment evaluation and clinical research purposes. Importantly, they are intended to help make the discourse analysis process more efficient and reliable. Teaching resources include an online tutorial on aphasia, videos of typical behaviors seen in aphasia, group treatment videos, classroom activities, tutorial screencasts, and conference posters. These resources can be used for a variety of clinical and educational purposes. The AphasiaBank website is part of the larger TalkBank project which provides many other shared databases and resources that are relevant to professionals interested in communication and communication disorders.

Conference posters

Conference posters

Association between Sensorineural Hearing Loss and Homozygous Sickle Cell Anemia: A Meta-Analysis

Introduction Sickle cell anemia (SCA) is caused by the homozygous inheritance of the βS allele (HbSS). SCA's destructive pathogenesis drives a state of continual oxidative stress and vascular inflammation due to accelerated auto-oxidation, iron de-compartmentalization, and inflammatory cell-derived oxidants. Continuous oxidative stress and vascular inflammation bolsters vaso-occlusion and ischemia-reperfusion cycling, impacting the functionality of multiple organ systems. The auditory system is particularly vulnerable to vaso-occlusive events as an end organ system. Repetitive damage secondary to recurrent SCA crises presents phenotypically as sensorineural hearing loss (SNHL), negatively impacting many children and adults living with SCA. A SCA crisis leads to stasis of the labyrinthine artery which supplies the inner ear, leading to hypoxia of the Organ of Corti and the Stria Vascularis within the cochlea and causing death of outer hair cells--important for amplification of sound. This results in permanent inner ear damage and hearing loss. Hearing loss in children has a documented negative effect on academic performance, speech and language development as well as self-image. For adults, hearing loss can have significant impact on career choices and effective communication in the workplace. Previous studies estimating the rate of SNHL in SCA suffer from significant design flaws, making broad application difficult. The major design flaws were: 1) no matched control population, 2) varying definitions of what qualifies as SNHL, and 3) absence of defined demographics within SCA and control groups. To address these flaws, a strict meta-analysis of the literature was performed comparing the prevalence of hearing loss in SCA and the general population. Methods & Results A comprehensive-- SCOPUS, PubMed, Google Scholar, and Medline--literature search was conducted to identify the prevalence of SCA pediatric SNHL, published between January 1970 and December 2018. Data was extracted by two reviewers per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, whereby there was no blinding to authors, journals of publication, or the results of the studies. Conference abstracts, posters, and single patient case reports were not excluded. Inclusion criteria included studies that examined exclusively SCA populations and rate of SNHL with a clearly defined threshold for hearing loss. Additionally, papers needed to include distinctly defined age ranges and a non-SCA control population. The initial search yielded 49 studies, with 21 studies meeting the inclusion criteria. Of the 21 studies identified, only 6 exclusively examined pediatric patients while the remaining were mixed adult/pediatric studies. To perform the analysis, we conducted a random effect (DerSimonian-Laird) meta-analysis. A Haldane-Anscombe correction was used to account for cases of no hearing loss within certain groups with small samples. The log odds ratio (LogOR) for SNHL in the mixed adult/pediatric population was 1.9 (95% CI 1.33 - 2.4) and the LogOR for SNHL in the pediatric only population was 1.4 (95% CI 0.781 - 2.1). These results indicate a strong association between SNHL and SCA in the adult and pediatric population. Conclusions SNHL among children can have deleterious impacts on their development, this meta-analysis showed a significant association between SCA and the development SNHL. The stronger association between SNHL in AN adult population compared to A pediatric population showed that there is worsening of SNHL over time secondary to SCA. At present, the data implies there should be an increase in audiological testing and screening in all patients diagnosed with SCA. (add in all forms of SCD) Clinical care providers should also make themselves aware of this under-reported and severe pathology in their patient population. The research community must also make efforts to standardize their approaches to measuring and observing this phenomenon to make certain that all future studies are clinically applicable and translatable. Figure Disclosures Vercellotti: Mitobridge, an Astellas Company: Consultancy, Research Funding.

The Sub-Saharan Africa Regional Partnership (SHARP) for Mental Health Capacity Building: a program protocol for building implementation science and mental health research and policymaking capacity in Malawi and Tanzania

BackgroundMental health (MH) disorders in low and middle-income countries (LMICs) account for a large proportion of disease burden. While efficacious treatments exist, only 10% of those in need are able to access care. This treatment gap is fueled by structural determinants including inadequate resource allocation and prioritization, both rooted in a lack of research and policy capacity. The goal of the Sub-Saharan Africa Regional Partnership for Mental Health Capacity Building (SHARP), based in Malawi and Tanzania, is to address those research and policy-based determinants.MethodsSHARP aims to (1) build implementation science skills and expertise among Malawian and Tanzanian researchers in the area of mental health; (2) ensure that Malawian and Tanzanian policymakers and providers have the knowledge and skills to effectively apply research findings on evidence-based mental health programs to routine practice; and (3) strengthen dialogue between researchers, policymakers, and providers leading to efficient and sustainable scale-up of mental health services in Malawi and Tanzania. SHARP comprises five capacity building components: introductory and advanced short courses, a multifaceted dialogue, on-the-job training, pilot grants, and “mentor the mentors” courses.DiscussionProgram evaluation includes measuring dose delivered and received, participant knowledge and satisfaction, as well as academic output (e.g., conference posters or presentations, manuscript submissions, grant applications). The SHARP Capacity Building Program aims to make a meaningful contribution in pursuit of a model of capacity building that could be replicated in other LMICs. If impactful, the SHARP Capacity Building Program could increase the knowledge, skills, and mentorship capabilities of researchers, policymakers, and providers regarding effective scale up of evidence-based MH treatment.

PCN133 A SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC BURDEN OF NEWLY DIAGNOSED MULTIPLE MYELOMA

Multiple myeloma (MM) is a cancer caused by malignant plasma cells, affecting the bone marrow. Globally, nearly 2.1 persons per 100,000 live with MM and an estimated 130,000 new cases occur annually. While previous reviews investigated the economic burden of MM, to date there is no record of published systematic evidence appraisals of the burden specifically in newly diagnosed MM (NDMM) populations. A systematic literature review (SLR) identifying studies (randomized and non-randomized clinical trials) published between 01/2005 and 11/2018 that reported on economic burden (direct/indirect costs, healthcare resource use) of NDMM in adult patients was conducted. The searched electronic databases included Medline/Embase/CEA-Registry/EconLit/Cochrane. Key conference (ASH/EHA/ASCO/ESMO/ISPOR) proceedings and posters were hand-searched. Case reports, non-systematic reviews, editorials/letters and non-English studies were excluded. Two researchers independently screened all studies and performed extraction. A total of 40 references (38 individual studies) reporting economic outcomes were identified. Of these, 29 studies reported direct cost data (of these, 21 reported treatment-specific direct cost data), while information on resource utilization was covered by 11 studies with 4 studies reporting both cost and resource utilization data. Only one study reported indirect costs (productivity loss). Published studies presenting direct cost analyses often varied considerably depending on the selection of cost components. For the US, total direct cost associated with NDMM of approximately $11,000-$16,000 per patient/month was reported. Inpatient admissions and adverse events were consistently reported as key cost drivers (20-60%). Regarding specific therapies, the addition of lenalidomide to various treatment regimens was shown to consistently result in a substantial cost increase (>70%). Productivity loss investigated by the one US study was valued at $14,467-$18,329 per patient/per year. These findings illustrate the existing economic burden of NDMM. However, more research is necessary for consistent evidence on the societal burden including indirect costs, productivity loss and caregiver burden associated with NDMM.

Mapping empirical experiences of Tom Kitwood's framework of person-centred care for persons with dementia in institutional settings. A scoping review.

Tom Kitwood's theoretical framework of person-centred care is extensively and internationally referred to in healthcare services. However, despite the broad use of Kitwood's approach in clinical practice, the research examining experiences with the approach has not been mapped. To map the available literature on current empirical experiences in clinical practice of Kitwood's approach to person-centred care for people with dementia, living in institutional settings in primary health care. A total of 154 studies concerning the experiences of people with dementia and their formal caregivers' use of Kitwood's framework of person-centred care for residents living in institutional settings in primary health care were compiled from scientific databases. All three authors engaged in a systematic selection process, leading to nineteen articles being included in the review. The results showed an overall tendency towards positive experiences gained from applying person-centred approaches in clinical practice influenced by Kitwood's theoretical framework. Through the synthesis of data from the selected studies, six categories related to our research aim were identified 'Theoretical evaluation of Tom Kitwood's model of care', 'Models and frameworks', 'Interventions', 'Communication', 'Dementia Care Mapping' and 'Environment'. The present review included nineteen studies published from 1998 to 2016 and consisted mainly of peer-reviewed scientific articles, followed by dissertations, conference posters and nonpeer-reviewed articles. All studies were undertaken in Western countries. The vast majority of the studies considered Kitwood's theoretical framework to be beneficial and useful in practice.

Six Insights to Make Better Academic Conference Posters

Six Insights to Make Better Academic Conference Posters

Lefamulin: a promising new pleuromutilin antibiotic in the pipeline

ABSTRACTIntroduction: Community-acquired bacterial pneumonia (CABP) represents a significant clinical and financial burden within infectious disease. In the advent of increasing resistance from bacteria such as Streptococcus pneumoniae to available antibiotic therapies, there is a need for new drugs with novel mechanisms to treat such infections.Areas covered: Lefamulin, the first semi-synthetic pleuromutilin for systemic administration, is nearing completion of Phase III studies for CABP; the manufacturer plans to file for a new drug application (NDA) in Q4 2018. This paper details available data on the pharmacokinetic, pharmacodynamic, in vitro and clinical data of the drug to date, derived from published literature, conference posters and data provided by the manufacturer.Expert commentary: Lefamulin offers a unique spectrum of activity as a potential monotherapy treatment agent for CABP and alternative to fluoroquinolone therapy. The drug displays potent activity against several pathogens common in both acute bacterial skin and skin structure infections (ABSSSIs) and CABP, and a lack of cross-resistance with other antibiotic classes for S. pneumoniae and Staphylococcus aureus. Lefamulin has met predefined noninferiority endpoints of clinical response for CABP compared to moxifloxacin ± linezolid in two Phase III trials (LEAP 1 and 2) and presents an alternative therapy for CABP.

Cost-Effectiveness Analyses of FDA-Approved Drugs for Cancer Indications, 2015-2017

Background:In addition to a drug's anti-tumor efficacy and tissue toxicity, it is now apparent that affordability is a pivotal factor determining the net therapeutic value of an anti-cancer compound. Cost-Effectiveness Analyses (CEA) are therefore key to appreciating the overall balance between the clinical and economical repercussions of a pharmaceutical agent. We aimed to investigate the cost-effectiveness data of newly approved drugs in cancer care.Methods:The FDA website was reviewed for all drugs approved for any cancer indication between the years 2015-2017. A systematic search of Pubmed and Google Scholar was conducted for Cost-Effectiveness Analyses (CEA) of each of these medications. Average Wholesale Prices were collected from Uptodate.com.Results:30 drugs were approved for cancer indications in 2015-2017. Each of the approved drugs had an average of 1.27 CEA studies (range 0-6). 4 of the 38 (10.5%) available CEAs were done before approval of an index drug. 18 (60%) of the approved medications had an available published CEA at the time of our search (March, 2018). Partition survival modelling (31.5%) and Markov modelling (26.3%) were the most common methods of analysis. 47.3% (18/38) of the CEAs were thought to reflect a favorable ICER per the analysis's investigators. The nature of the malignancy (solid versus hematologic) did not distinguish between the mean number of a drug's CEAs (1.25; 1.2) but drugs for solid cancer indications were less likely to be associated with a favorable CE assessment compared with hematological cancers (47.8% versus 58.3%). “Expensive” drugs (defined as monthly cost greater than 8,618 dollars) had a lower mean number of CEA studies than “less expensive” drugs (1.09 versus 1.36) and were less likely to be associated with a favorable cost-effectiveness profile (27.2% versus 73.6%). 47.3% (18/38) of the economic evaluations were published as conference proceeding/abstract, 36.8% (14/38) were in the form of a full-text article, and the remainder as journal letters or conference posters (6/38; 15.7%).Conclusion:Insufficient data on the cost-effectiveness profile of novel anti-cancer medications jeopardises our ability to determine their real value. Although these drugs are being routinely used in a large-scale fashion, gaps persist as to their financial harm relative to the associated (potential) clinical benefit. Our study shows that recently-approved anti-cancer drugs have a very small number of CEAs to back their clinical-societal merit. Paradoxically, more costly drugs have fewer CEAs compared with cheaper drugs. Also of note, the majority of the analyses followed the approval of the drug, were published in a non full-text format, and were associated with non-sustainable ICER values. We argue that publication of rigorous, peer-reviewed CEAs should be a mandatory pre-approval step for academia/industry and serve as a pre-requisite to the routine distribution and usage of new cancer-directed medications. DisclosuresNo relevant conflicts of interest to declare.

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: ASystematic Review and Meta-analysis of Observational Studies.

The 13-valent pneumococcal conjugate vaccine (PCV13) is the only licensed PCV with serotype 3 polysaccharide in its formulation. Postlicensure PCV13 effectiveness studies against serotype 3 invasive pneumococcal disease (IPD) in children have shown inconsistent results. We performed a systematic review and meta-analysis of observational studies to assess PCV13 vaccine effectiveness (VE) for serotype 3 IPD in children. We systematically searched PubMed, Embase, and the Cochrane library for studies published before 14 August 2017. We identified 4 published studies and 2 conference posters that provided PCV13 VE estimates stratified by serotype. The pooled PCV13 VE against serotype 3 IPD from the random-effects meta-analysis was 63.5% (95% confidence interval [CI], 37.3%–89.7%). A sensitivity analysis including conference posters gave a pooled VE estimate of 72.4% (95% CI, 56.7%–88.0%). The pooled data from case-control studies with similar methodologies and high quality support direct PCV13 protection against serotype 3 IPD in children.

EERA DeepWind’2018, 15th Deep Sea Offshore Wind R&D Conference

PREFACEThis Special Issue presents selected papers from EERA DeepWind’2018, 17 – 19 January, Trondheim, Norway. This was the 15th Deep Sea Offshore Wind R&D Conference. The conference is hosted by SINTEF and NTNU and organized in cooperation with the European Energy Research Alliance (EERA) joint programme on wind energy. A total of 37 papers are included addressing the research topics of the conference:▪ New turbine and generator technology▪ Grid connection and power system integration▪ Met-ocean condition▪ Operation and maintenance▪ Installation and sub-structures▪ Wind farm optimization▪ Experimental testing and validation▪ Wind farm control systemsAll papers presented in this special issue have gone through a careful peer-review organized by the international Scientific Committee of EERA DeepWind’2018:Anaya-Lara, Olimpo, Strathclyde UniversityBredmose, Henrik, DTUBusmann, Hans-Gerd, Fraunhofer IWESEecen, Peter, ECNFurevik Birgitte R., METHeggelund, Yngve, CMRJørgensen, Hans Ejsing, DTUKvamsdal, Trond, NTNULeithead, William, Strathclyde UniversityMadsen, Peter Hauge, DTUMerz, Karl, SINTEF EnergiMuskulus, Michael, NTNUNielsen, Finn Gunnar, UiBNygaard, Tor Anders, IFEReuder, Joachim, UiBRobertson, Amy, NRELRohrig, Kurt, Fraunhofer IEETande, John Olav, SINTEF EnergiUhlen, Kjetil, NTNUVan Bussel, Gerard, TU DelftVan Wingerde, Arno, Fraunhofer IWESWelte, Thomas, SINTEF EnergiWiggert, Marcel, Fraunhofer IWESØkland, Ole David, SINTEF OceanAcknowledgementsThe financial support from the Research Council of Norway covering a share of the cost of organizing the conference is greatly appreciated. The conference chairs and guest editors of this Special Issue like to express our sincere gratitude to the Scientific Committee of EERA DeepWind‘2018, all authors that have contributed to this Special Issue, and to colleagues that have so kindly contributed to the review process. We hope that this Special Issue provides results that contribute to the fruitful development of offshore wind energy. Details of the DeepWind’2018 conference and all conference presentations and posters are available at the conference web page.Conference chairs and guest editors:John Olav Giæver Tande, Chief Scientist, SINTEF Energi Trond Kvamsdal, Professor, NTNU Michael Muskulus, Professor, NTNU

Speaking for the trees: The real Lorax and upcycled conference posters

On the trail of the Lorax Dr. Seuss’s fanciful Lorax may have a real-life inspiration, with a scientific paper to back up the claim. A team reports that the patas monkey (Erythrocebus patas) may have been the muse for the conservationist Lorax, who speaks for the trees in Seuss’s famous tale of the same name (Nat. Ecol. Evol. 2018, DOI: 10.1038/s41559-018-0628-x). When Nathaniel J. Dominy, an evolutionary biologist, and Donald E. Pease, an English professor and Seuss biographer, got to talking at Dartmouth College—Seuss’s alma mater where both Dominy and Pease work—they homed in on Kenya’s patas monkey. Dominy remarked that the patas monkey, familiar to him from fieldwork, resembled a Seuss character. Meanwhile, Pease noted that Theodor Seuss Geisel (Seuss’s real name) had written 90% of “The Lorax” while visiting Kenya in 1970. What’s more, the patas monkey makes a whistling noise that could have inspired the “sawdusty sneeze”

Creating a Conference Poster with High-Resolution Network Figures

Abstract Creating a poster with high-resolution network images can be a challenging task. In this article, the process of exporting a network figure from a network analysis tool, importing it in a vector graphics tool, and preparing the poster for print is discussed. The steps include critical strategies for producing print-quality figures that also apply to the preparation of network figures for journal publication. We discuss different file formats and argue that the favorite tool for creating conference posters – Microsoft PowerPoint – is not suitable for posters that include network figures. Instead, we suggest the use of Inkscape, a free and open-source tool, or a comparable vector graphics tool to prepare your posters. The goal of this article is to provide a tutorial-like description of the critical steps for creating a conference poster with high-resolution network figures.

Conference Posters

List of Conference Posters are available in this pdf.

Impact of inhalational anesthetics on postoperative cognitive function

Background:Conflict findings of the impact of inhalational anesthetics on postoperative cognitive function are reported. No systematic review has been performed to solve the problem. The aim of the study was to assess the effect of different inhalational anesthetics on postoperative cognitive function in a network meta-analysis.Methods:We will search MEDLINE, EMBASE, the Central Register of Controlled Trials in the Cochrane library, and CINAHL for randomized controlled trials or cohort studies assessing the short-term or long-term cognitive function of elderly patients (over 60 years) receiving major surgeries and inhalational anesthetics (desflurane, isoflurane, sevoflurane, halothane, and nitrous oxide) during surgery. Two reviewers will independently screen study eligibility, extract information from eligible studies, and appraise study quality. The impact of inhalational anesthetics will be assessed through: incidence of postoperative cognitive dysfunction at 1 week, 3 months, 1 year, and over 1 year after surgery; incidence of post-operative delirium; test of postoperative cognitive function.Results:The results of this systematic review and meta-analysis will be published in a peer-reviewed journal.Conclusion:To our knowledge, this systematic review will be the first to evaluate existing research on the incidence of postoperative cognitive function after inhalational anesthetics. Our study will assess the effect of different inhalational anesthetics on postoperative cognitive function.Ethics and dissemination:The review will be finished in December 2017, and the result will be published in a peer-reviewed journal or disseminated through conference posters or abstracts.Review registration number:CRD42017056675 (www.crd.york.ac.uk/PROSPERO).

Conduction, Evaluation, and Future Considerations for an Obesity Educator Training Program in Korea

To reduce the prevalence of obesity and provide information on evidence-based obesity treatments, the Education Committee of the Korean Society for the Study of Obesity (KSSO) has developed and launched the first Obesity Educator Training Program (OETP). After the course, we analyzed the results of a survey from 110 participants, comprising medical doctors (n=58), nutrition specialists (n=19), exercise specialists (n=14), and students (n=6). Approximately half of the participants were recruited through the Internet (48%), followed by academic leaflets, such as conference posters (21%); the reasons for participation were to learn about evidence-based treatments for obesity (47%), to receive up-to-date knowledge on obesity treatments (39%), to obtain basic information on obesity (10%), and others (4%). More than half of the participants found the date, lecture time, process, and theme of the OETP favorable. The participants indicated that there should be an in-depth course, sharing of the presented files with attendees, a longer lecture time, and a broader OETP that includes other specialties such as nursing. To improve the OETP, the educational committee of the KSSO must develop an in-depth OETP that will reflect these participant’s feedback.